Atrial Appendage

• 

  Subject Areas on Research

  • Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation. 
  • Assessment of Device-Related Thrombus and Associated Clinical Outcomes With the WATCHMAN Left Atrial Appendage Closure Device for Embolic Protection in Patients With Atrial Fibrillation (from the PROTECT-AF Trial). 
  • Association Between Left Atrial Appendage Occlusion and Readmission for Thromboembolism Among Patients With Atrial Fibrillation Undergoing Concomitant Cardiac Surgery. 
  • Beta(2)-adrenergic and several other G protein-coupled receptors in human atrial membranes activate both G(s) and G(i). 
  • Comparative Safety of Transcatheter LAAO With the First-Generation Watchman and Next-Generation Watchman FLX Devices. 
  • Cost-Effectiveness of Left Atrial Appendage Occlusion: A Case Based on Facts Not in Evidence? 
  • Detailed thrombogenicity phenotyping and 1 year outcomes in patients undergoing WATCHMAN implantation: (TARGET-WATCHMAN) a case-control study. 
  • Development and validation of an automated algorithm for end point adjudication for a large U.S. national registry. 
  • Device-Related Thrombus After Left Atrial Appendage Occlusion: The Villain of the Piece. 
  • Device-Sizing and Associated Complications With Left Atrial Appendage Occlusion: Findings From the NCDR LAAO Registry. 
  • Expression of heat shock proteins in myocardium of patients with atrial fibrillation. 
  • Getting (Left Atrial Appendage) Closure With Kidney Disease. 
  • Incidence and Predictors of Left Atrial Appendage Thrombus in Patients Treated With Nonvitamin K Oral Anticoagulants Versus Warfarin Before Catheter Ablation for Atrial Fibrillation. 
  • Increased Left Atrial Appendage Density on Computerized Tomography is Associated with Cardioembolic Stroke. 
  • Indications for Left Atrial Appendage Occlusion in the United States and Associated In-Hospital Outcomes: Results From the NCDR LAAO Registry. 
  • Interventions for Preventing Thromboembolic Events in Patients With Atrial Fibrillation: A Systematic Review. 
  • Left Atrial Appendage Closure for Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation: the LAA-CAA Cohort. 
  • Left Atrial Appendage Closure: Two Steps Forward, One Step Back. 
  • Left Atrial Appendage Electrical Isolation for Treatment of Recurrent Atrial Fibrillation: A Meta-Analysis. 
  • Left Atrial Appendage Morphology Improves Prediction of Stagnant Flow and Stroke Risk in Atrial Fibrillation. 
  • Left Atrial Appendage Morphology and Embolic Stroke of Undetermined Source: A Cross-Sectional Multicenter Pilot Study. 
  • Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation : A Decision Analysis. 
  • Left Atrial Appendage Thrombus and Embolic Stroke. 
  • Left atrial appendage anatomy and function: short term response to sustained atrial fibrillation. 
  • Left atrial appendage characteristics and the risk of stroke: Sorting out the contenders from the pretenders. 
  • Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation. 
  • Left atrial appendage occlusion: rationale, evidence, devices, and patient selection. 
  • Left atrial appendage to great cardiac vein fistula complicating watchman left atrial appendage closure. 
  • PRO editorial: PRO: three-dimensional transesophageal echocardiography is a major advance for intraoperative clinical management of patients undergoing cardiac surgery. 
  • Patient-Level Analysis of Watchman Left Atrial Appendage Occlusion in Practice Versus Clinical Trials. 
  • Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. 
  • Percutaneous left atrial appendage occlusion: A review of current devices, clinical evidence, patient selection, and post procedural antithrombotic management. 
  • Periprocedural Pericardial Effusion Complicating Transcatheter Left Atrial Appendage Occlusion: A Report From the NCDR LAAO Registry. 
  • Postprocedural Antithrombotic Therapy Following Left Atrial Appendage Occlusion: No Longer Adrift in Uncertainty? 
  • Predicting AF recurrence after catheter ablation: Is it time to use the force? 
  • Prevalence and clinical characteristics associated with left atrial appendage thrombus in fully anticoagulated patients undergoing catheter-directed atrial fibrillation ablation. 
  • Risk stratification for stroke in atrial fibrillation: a critique. 
  • Screening for Atrial Fibrillation With a Wearable Device. 
  • Selective activation of human atrial Galpha12 and Galpha13 by Galphaq-coupled angiotensin and endothelin receptors. 
  • Sex Differences in Procedural Outcomes Among Patients Undergoing Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry. 
  • Subclavian vein to right atrial appendage bypass without sternotomy to maintain arteriovenous access in patients with complete central vein occlusion, a new approach. 
  • Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine. 
  • The case of the disappearing myxoma. 
  • The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. 
  • The left atrial appendage morphology is associated with embolic stroke subtypes using a simple classification system: A proof of concept study. 
  • Thoracoscopic resection of the left atrial appendage after failed focal atrial tachycardia ablation. 
  • Thromboembolism after WATCHMANTM in a clopidogrel non-responder: A case for concern? 
  • Thrombogenesis in atrial fibrillation contributing mechanisms and natural history. 
  • Use of left atrial appendage occlusion among older cardiac surgery patients with preoperative atrial fibrillation: a national cohort study. 
  • Watchman implantation in a patient with left atrial appendage thrombus. 
  • When the body and appendage of the left atrium disagree: "Focal" atrial fibrillation-implications for atrial thrombus formation and risk of thromboembolism. 
  • Women in procedural leadership roles in cardiology: The Women In Local Leadership (WILL) observational study.